-
Case Studies
NewMountain Tourism – Case Study
Mountain Tourism Report Overview The mountain tourism case study offers detailed insights into the key destinations with opportunities and challenges faced by the industry. Mountains are important tourist destinations around the world and attract visitors for their picturesque beauty, sports attractions, and rich cultural and spiritual heritage. The expansion of transportation networks and digitalization has led to an increased interest in mountain tourism both for adventure and wellness. Mountain tourism allows tourists to witness and experience the environment in a...
-
Product Insights
NewLikelihood of Approval Analysis for Anemia
Overview How likely is it that the drugs in Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia Overview Anemia is a condition characterized by insufficient healthy red blood cells...
-
Product Insights
NewLikelihood of Approval Analysis for Iron Deficiency Anemia
Overview How likely is it that the drugs in Iron Deficiency Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Iron Deficiency Anemia Overview Anemia is a condition in which the...
-
Product Insights
NewLikelihood of Approval Analysis for Gouty Arthritis (Gout)
Overview How likely is it that the drugs in Gouty Arthritis (Gout) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gouty Arthritis (Gout) Overview Gout is a type of arthritis where...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Polatuzumab Vedotin in T-Cell Lymphomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Polatuzumab Vedotin in T-Cell Lymphomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polatuzumab Vedotin in T-Cell Lymphomas Drug Details: Polatuzumab vedotin (Polivy /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma Drug Details: Polatuzumab vedotin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Polatuzumab Vedotin in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Polatuzumab Vedotin in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polatuzumab Vedotin in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FB-418 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FB-418 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FB-418 in Parkinson's Disease Drug Details: FB-418 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FB-418 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FB-418 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FB-418 in Amyotrophic Lateral Sclerosis Drug Details: FB-418 is under development...